Ceftobiprole: a clinical view.
Rev Esp Quimioter
; 34 Suppl 1: 32-34, 2021 Sep.
Article
en En
| MEDLINE
| ID: mdl-34598421
ABSTRACT
Ceftobiprole is a broad-spectrum, fifth-generation cephalosporin currently approved for community-acquired and non-ventilator-associated hospital-acquired pneumonia. High bactericidal and anti-biofilm activity has been exhibited in in vitro and animal models. This, together with its synergism with other antibiotics against gram-positive bacteria, makes it an ideal candidate for treatment of complex infections, such as those associated with devices or infective endocarditis. More clinical data are needed to achieve drug positioning.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Cefalosporinas
/
Endocarditis Bacteriana
Límite:
Animals
Idioma:
En
Año:
2021
Tipo del documento:
Article